GlassScriptPhysician profile
Brandon Christopher Cain
NPI 1730407040
$7,428.13
in general payments reported to CMS, 2019-2025
25 companies · $432 in 2025
The $432 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,132 · 2020: $577 · 2021: $396 · 2022: $1,059 · 2023: $1,063 · 2024: $769 · 2025: $432.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,247 · Travel and Lodging: $17.86.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,246.59 |
| Travel and Lodging | $17.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $2,136.86 | 2019-2024 | Gore Tag Conformable Thoracic Endoprosthesis, Gore Viabahn Endoprosthesis With Heparin, Excluder Conformable Aaa Endoprosthesis With Active Control |
| Boston Scientific Corporation | $1,712.75 | 2019-2024 | Eluvia |
| Silk Road Medical, INC. | $863.59 | 2019-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Inari Medical, INC. | $513.94 | 2019-2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Cook Medical LLC | $395.24 | 2019-2025 | Zenith Alpha, Cook, Zilver Ptx |
| Medtronic, INC. | $374.47 | 2022-2024 | Endurant Iis |
| Angiodynamics, INC. | $275.36 | 2020-2024 | Venacure 1470 Pro |
| Stryker Corporation | $229.58 | 2025 | Clottriever Bold Catheter, Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Cardiovascular Systems INC. | $188.90 | 2020-2022 | |
| Endologix LLC | $148.11 | 2022 | |
| Amgen INC. | $123.16 | 2021-2025 | Repatha, Repatha |
| Chiesi USA, INC. | $77.67 | 2020 | |
| Abbott Laboratories | $64.24 | 2019-2023 | Diamondback Coronary |
| Janssen Pharmaceuticals, INC | $61.85 | 2019-2021 | |
| Medtronic Vascular, INC. | $58.68 | 2019 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $49.04 | 2023-2024 | Lifevest |
| Lemaitre Vascular, INC. | $35.92 | 2022-2024 | Artegraft Vascular Graft |
| Edwards Lifesciences Corporation | $28.01 | 2024 | Sapien 3 Ultra Resilia |
| Teleflex LLC | $14.14 | 2019 | |
| Covidien LP | $13.84 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $13.44 | 2020 | |
| Aroa Biosurgery Incorporated | $13.17 | 2023 | |
| Novartis Pharmaceuticals Corporation | $12.86 | 2022 | |
| Terumo Medical Corporation | $11.94 | 2020 | |
| Surmodics, INC. | $11.37 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brandon Cain listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.